Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Asset Utilization Ratio (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.72 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 15.11% to 0.72 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.72 through Dec 2025, down 15.11% year-over-year, with the annual reading at 0.8 for FY2025, 8.51% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.72 at Gyre Therapeutics, up from 0.69 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 16.8 in Q3 2023, with the low at 0.07 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 2.07, with a median of 0.79 recorded in 2025.
  • The sharpest move saw Asset Utilization Ratio tumbled 193.37% in 2022, then soared 34359.16% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.08 in 2021, then skyrocketed by 2199.38% to 1.77 in 2022, then increased by 1.5% to 1.79 in 2023, then crashed by 52.95% to 0.84 in 2024, then dropped by 15.11% to 0.72 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.72, 0.69, and 0.72 for Q4 2025, Q3 2025, and Q2 2025 respectively.